Therapeutic opportunities within the DNA damage response.

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• The DNA damage response (DDR) is vital for maintaining genomic integrity.
• Disruptions in DDR pathways are a hallmark of cancer.
• Targeting DDR components offers a promising strategy for cancer therapy.

Purpose of the Study:

• To provide an in-depth analysis of 450 curated human DDR genes.
• To explore the function, role in cancer, and therapeutic potential of DDR genes.
• To identify novel therapeutic targets within the DDR pathway.

Main Methods:

• Expert curation of 450 human DDR genes.
• Analysis of large-scale genomic and expression data across 15 cancer types.
• Systematic computational analysis to identify druggable DDR proteins.

Main Results:

• Comprehensive overview of DDR gene function and cancer relevance.
• Identification of deregulated DDR components in various cancers.
• Highlighting of DDR proteins as potential targets for small molecule therapeutics.

Conclusions:

• DDR proteins represent a rich source of potential cancer drug targets.
• Understanding DDR pathway dysregulation is key to developing novel cancer therapies.
• Computational approaches can effectively identify druggable targets within complex biological pathways.